![Todd Watanabe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Watanabe
Directeur Général chez
ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 23 M $ au 31/08/2026
Profil
Mr. Todd F.
Watanabe is a President, Chief Executive Officer & Director at Arcutis Biotherapeutics, Inc. He is on the Board of Directors at Amunix Pharmaceuticals, Inc. and Arcutis Biotherapeutics, Inc. Mr. Watanabe was previously employed as a Chief Operating Officer by Kanan Therapeutics, Inc. and a VP-Strategy & Corporate Development by Kythera Biopharmaceuticals Inc. He received his undergraduate degree from Georgetown University and a graduate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/08/2026 | 950 337 ( 0,76 % ) | 23 M $ | 31/08/2026 |
Postes actifs de Todd Watanabe
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur Général | 01/04/2017 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Directeur/Membre du Conseil | 23/06/2021 |
Anciens postes connus de Todd Watanabe
| Sociétés | Poste | Fin |
|---|---|---|
Kanan Therapeutics, Inc. | Fondateur | 01/02/2018 |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01/11/2015 |
Formation de Todd Watanabe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Kanan Therapeutics, Inc. |
